EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, COCP: Cocrystal Pharma Inc

28 Oct 25 18:43
LAST:

1.150

CHANGE:
 0.08		OPEN:
1.240		HIGH:
1.240		ASK:
0.000		VOLUME:
284.2K
CHG(%):
6.50		PREV:
1.230		LOW:
1.130		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
28 Oct 251.2401.2401.1301.150284.2K
27 Oct 251.2701.2971.1601.230788.0K
24 Oct 251.0901.2001.0901.180471.2K
23 Oct 251.0201.0801.0101.060201.1K
22 Oct 251.0501.0701.0101.030231.8K
21 Oct 251.1001.1001.0401.06084.8K
20 Oct 251.0801.1201.0401.090145.8K
17 Oct 251.0501.0801.0301.070121.5K
16 Oct 251.0601.0891.0401.070159.3K
15 Oct 251.0701.0701.0401.05089.2K

COMPANY PROFILE

Name:Cocrystal Pharma Inc
About:Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. It employs structure-based technologies to create antiviral drugs including influenza virus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as norovirus, respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, a HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was founded in 2006 and is based in Bothell, Washington.
Sector:Healthcare
Industry:Biotechnology
Address:19805 North Creek Parkway, Bothell, WA, United States, 98011
Website:https://www.cocrystalpharma.com
CUSIP:09072E103
CIK:0001412486
ISIN:US19188J4094
FIGI:BBG000V27360

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:1.131.8%
MA10:1.104.6%
MA20:1.140.6%
MA50:1.3113.9%
MA100:1.4627.3%
MA200:1.5535.1%
STO9:44.94
STO14:44.94
RSI14:41.67
WPR14:-40.00
MTM14:-0.07
ROC14:-0.06 
ATR:0.08 
Week High:1.3012.8%
Week Low:1.0113.9%
Month High:1.3113.9%
Month Low:1.0135.1%
Year High:3.26183.5%
Year Low:1.0113.9%

RECENT SPLITS

Date Ratio
11 Oct 20221-12
24 Jan 20181-30